Balyasny Asset Management LLC Nevro Corp Call Options Transaction History

Balyasny Asset Management LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $1.96 Million - $2.67 Million	65,000 New	65,000 $2.35 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $13.6 Million - $17.7 Million	334,700 New	334,700 $15.6 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.